min read
share fall 6 percent fda sanction
karkhadi plant make drug ingredi formul
dr reddi recal heartburn drug unit state
siddiqui chatterje
mumbai march 13 reuter us food drug administr fda ha ban import indian gener drugmak sun pharmaceut industri ltd plant karkhadi western state gujarat latest qualiti blow india drug sector
fda ha impos rash regulatori sanction indian gener maker last year trigger concern qualiti medicin suppli 14 billion industri countri includ unit state biggest market
india second onli canada drug export unit state suppli 40 percent gener overthecount drug
fda becom stringent learn curv everyon invest said bk secur analyst rohit compani pull qualiti paramet
wa immedi clear whi fda impos ban sun pharma karkhadi plant
fda issu import alert factori websit said wednesday agenc defin sanction someth result detent without physic examin drug firm met socal good manufactur practic
ban plant underscor grow concern qualiti medicin made india often refer lowcost pharmaci world demand gener grow countri unit state japan
sun pharma spokeswoman said financi impact fda ban us shipment plant make antibiot cephalosporin would neglig plant account less 1 percent overal sale said
sun pharma also said initi sever correct step address fda concern kept guidanc consolid sale fiscal year end thi month
karkhadi plant one sun pharma 25 manufactur plant 11 india three plant includ karkhadi plant gujarat
share sun fell much 64 percent thursday
industri offici india say weak local regulatori oversight lax approach qualiti control drugmak rush tap grow global demand gener result substandard manufactur process
urgenc first gener version drug come patent one reason qualiti problem say compani first launch drug enjoy sixmonth exclus period lucr gener version commerci blockbust
fda last month call collabor indian regul improv drug qualiti ha ban import indian plant ranbaxi laboratori ltd india no1 drugmak sale product qualiti laps
separ rival drug maker dr reddi laboratori ltd start recal bottl heartburn drug unit state januari due microbi contamin inform post fda websit wednesday show
spokesman dr reddi wa immedi avail comment
also thi month fda announc drug recal ranbaxi sun pharma
india wockhardt ltd ha also bar export drug plant unit state britain
drug ranbaxi wockhardt indian peer includ dr reddi lupin ltd export unit state cheaper copi drug expir patent protect
compani small manag strong supervis compani get bigger supervis break said chief execut offic top indian drugmak
need system cultur maintain proper supervis process grow think said ceo declin identifi
quot delay minimum 15 minut see complet list exchang delay
reuter right reserv
